問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
楊思婷
下載
2025-03-01 - 2032-01-31
Condition/Disease
Ovarian Cancer
Test Drug
Frozen Crystal Injection
Participate Sites7Sites
Recruiting7Sites
2025-11-19 - 2030-06-30
Platinum-based therapy-resistant epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer
Navicixizumab
Participate Sites10Sites
Recruiting10Sites
2024-08-15 - 2026-12-31
Participate Sites9Sites
Not yet recruiting5Sites
Recruiting4Sites
2026-05-15 - 2028-04-30
Participate Sites2Sites
Recruiting2Sites
2024-04-01 - 2029-12-31
Participate Sites3Sites
Recruiting3Sites
2024-12-01 - 2028-12-31
2026-05-01 - 2029-12-31
2025-03-01 - 2030-03-31
Participate Sites6Sites
Recruiting6Sites
2025-07-10 - 2029-08-30
2024-02-12 - 2028-11-18
全部
